Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations in hemodialysis patients (Q40874153)

24 September 2017

Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations in hemodialysis patients (English)

1 reference

24 September 2017

0 references

Arnadottir M

1

1 reference

24 September 2017

Berg AL

2

1 reference

24 September 2017

Dallongeville J

3

1 reference

24 September 2017

Fruchart JC

4

1 reference

24 September 2017

Nilsson-Ehle P

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

24 September 2017

1 reference

24 September 2017

52

1 reference

24 September 2017

1651-1655

1 reference

24 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1997.498

24 September 2017

0 references

cites work

Prevalence of serum lipid abnormalities in chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Increased lipoprotein-remnant formation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Serum apolipoprotein profile of patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Very-low-density lipoprotein of uremic patients is a poor substrate for bovine lipoprotein lipase in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Direct effects of corticotropin on plasma lipoprotein metabolism in man--studies in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Counterregulatory hormonal response to insulin-induced hypoglycemia in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Different types of heparin in haemodialysis: long-term effects on post-heparin lipases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.498

7 January 2021

Identifiers

DOI

10.1038/KI.1997.498

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference